Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, komentáře
Grantová podpora
NNF17OC0028608.
AgNovos Healthcare
PubMed
37330928
PubMed Central
PMC10354110
DOI
10.1007/s00134-023-07114-8
PII: 10.1007/s00134-023-07114-8
Knihovny.cz E-zdroje
- Klíčová slova
- Cognitive function, Critical illness, Intravenous fluid, Long-term outcomes, Quality of life, Sepsis, Septic shock,
- MeSH
- dospělí MeSH
- jednotky intenzivní péče MeSH
- kvalita života MeSH
- lidé MeSH
- péče o pacienty v kritickém stavu MeSH
- přežívající MeSH
- septický šok * terapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- komentáře MeSH
PURPOSE: To assess long-term outcomes of restrictive versus standard intravenous (IV) fluid therapy in adult intensive care unit (ICU) patients with septic shock included in the European Conservative versus Liberal Approach to Fluid Therapy in Septic Shock in Intensive Care (CLASSIC) trial. METHODS: We conducted the pre-planned analyses of mortality, health-related quality of life (HRQoL) using EuroQol (EQ)-5D-5L index values and EQ visual analogue scale (VAS), and cognitive function using Mini Montreal Cognitive Assessment (Mini MoCA) test at 1 year. Deceased patients were assigned numerical zero for HRQoL as a state equal to death and zero for cognitive function outcomes as worst possible score, and we used multiple imputation for missing data on HRQoL and cognitive function. RESULTS: Among 1554 randomized patients, we obtained 1-year data on mortality in 97.9% of patients, HRQoL in 91.3%, and cognitive function in 86.3%. One-year mortality was 385/746 (51.3%) in the restrictive-fluid group versus 383/767 (49.9%) in the standard-fluid group, absolute risk difference 1.5%-points [99% confidence interval (CI) - 4.8 to 7.8]. Mean differences were 0.00 (99% CI - 0.06 to 0.05) for EQ-5D-5L index values, - 0.65 for EQ VAS (- 5.40 to 4.08), and - 0.14 for Mini MoCA (- 1.59 to 1.14) for the restrictive-fluid group versus the standard-fluid group. The results for survivors only were similar in both groups. CONCLUSIONS: Among adult ICU patients with septic shock, restrictive versus standard IV fluid therapy resulted in similar survival, HRQoL, and cognitive function at 1 year, but clinically important differences could not be ruled out.
1st Department of Anaesthesiology and Intensive Therapy Medical University Lublin Lublin Poland
Anaesthesia and Intensive Care Medicine IRCCS Humanitas Research Hospital Rozzano Milan Italy
Anesthesia and Intensive Care Unit Azienda Ospedaliero Universitaria Delle Marche Ancona Italy
Anesthesia and Intensive Care Unit Humanitas Research Hospital Castellanza Italy
Clinical Trial Unit Intensive Care National Audit and Research Centre London UK
Collaboration for Research in Intensive Care Copenhagen Denmark
Copenhagen Academy for Medical Education and Simulation Rigshospitalet Copenhagen Denmark
Department of Anaesthesia and Intensive Care Aalborg University Hospital Aalborg Denmark
Department of Anaesthesia and Intensive Care Capio St Görans Hospital Stockholm Sweden
Department of Anaesthesia and Intensive Care Herning Hospital Herning Denmark
Department of Anaesthesia and Intensive Care Holbæk Hospital Holbæk Denmark
Department of Anaesthesia and Intensive Care Humanitas Gavazzeni Hospital Bergamo Bergamo Italy
Department of Anaesthesia and Intensive Care Randers Hospital Randers Denmark
Department of Anaesthesia and Intensive Care Viborg Hospital Viborg Denmark
Department of Anaesthesia and Intensive Care Zealand University Hospital Køge Denmark
Department of Anaesthesia and Intensive Care Zealand University Hospital Roskilde Denmark
Department of Anesthesia and Intensive Care Medicine Hospital Østfold Kalnes Grålum Norway
Department of Anesthesia and Intensive Care Oslo University Hospital Ullevål Oslo Norway
Department of Biomedical Sciences and Public Health Università Politecnica Delle Marche Ancona Italy
Department of Biomedical Sciences Humanitas University Pieve Emanuele Milan Italy
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Emergency Medicine Capio St Görans Hospital Stockholm Sweden
Department of Intensive Care Guy's and St Thomas' Hospital London UK
Department of Intensive Care Hospital Innland Hamar Hamar Norway
Department of Intensive Care Medicine Stavanger University Hospital Stavanger Norway
Department of Intensive Care Medicine University Hospital Bern University of Bern Bern Switzerland
Department of Intensive Care Medicine University Hospital Brussels Jette Belgium
Department of Perioperative Medicine and Intensive Care Karolinska University Hospital Solna Sweden
Faculty of Medicine and Pharmacy Vrije Universiteit Brussel Brussels Belgium
Institute of Clinical Medicine University of Oslo Oslo Norway
Intensive Care Unit Basel University Hospital Basel Switzerland
Section of Biostatistics Department of Public Health University of Copenhagen Copenhagen Denmark
Zobrazit více v PubMed
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181–1247. doi: 10.1007/s00134-021-06506-y. PubMed DOI PMC
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet. 2020;395:200–211. doi: 10.1016/S0140-6736(19)32989-7. PubMed DOI PMC
Mostel Z, Perl A, Marck M, et al. Post-sepsis syndrome—an evolving entity that afflicts survivors of sepsis. Mol Med. 2019;26:6. doi: 10.1186/s10020-019-0132-z. PubMed DOI PMC
Thompson K, Venkatesh B, Finfer S. Sepsis and septic shock: current approaches to management. Intern Med J. 2019;49:160–170. doi: 10.1111/imj.14199. PubMed DOI
Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304:1787–1794. doi: 10.1001/jama.2010.1553. PubMed DOI PMC
Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386:2459–2470. doi: 10.1056/NEJMoa2202707. PubMed DOI
(2023) Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med 388:499–510. 10.1056/NEJMoa2212663 PubMed PMC
Meyhoff TS, Møller MH, Hjortrup PB, et al. Lower versus higher fluid volumes during initial management of sepsis—a systematic review with meta-analysis and trial sequential analysis. Chest. 2020 doi: 10.1016/j.chest.2019.11.050. PubMed DOI
Sivapalan P, Ellekjaer KL, Jessen MK, et al. Lower vs higher fluid volumes in adult patients with sepsis—an updated systematic review with meta-analysis and trial sequential analysis. Chest. 2023 doi: 10.1016/j.chest.2023.04.036. PubMed DOI PMC
Clermont G, Kong L, Weissfeld LA, et al. The effect of pulmonary artery catheter use on costs and long-term outcomes of acute lung injury. PLoS ONE. 2011;6:e22512. doi: 10.1371/journal.pone.0022512. PubMed DOI PMC
Mikkelsen ME, Christie JD, Lanken PN, et al. The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med. 2012;185:1307–1315. doi: 10.1164/rccm.201111-2025OC. PubMed DOI PMC
Kjær M-BN, Meyhoff TS, Madsen MB, et al. Long-term patient-important outcomes after septic shock: A protocol for 1-year follow-up of the CLASSIC trial. Acta Anaesthesiol Scand. 2020;64:410–416. doi: 10.1111/aas.13519. PubMed DOI
Meyhoff TS, Hjortrup PB, Møller MH, et al. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2019 doi: 10.1111/aas.13434. PubMed DOI
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801–810. doi: 10.1001/jama.2016.0287. PubMed DOI PMC
Brueton VC, Tierney J, Stenning S, et al. Strategies to improve retention in randomised trials. Cochrane Database Syst Rev. 2013 doi: 10.1002/14651858.MR000032.pub2. PubMed DOI PMC
Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72. doi: 10.1016/0168-8510(96)00822-6. PubMed DOI
Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20:1727–1736. doi: 10.1007/s11136-011-9903-x. PubMed DOI PMC
Wong A, Nyenhuis D, Black SE, et al. The MoCA 5-min protocol is a brief, valid, reliable and feasible cognitive screen for telephone administration. Stroke J Cereb Circ. 2015;46:1059–1064. doi: 10.1161/STROKEAHA.114.007253. PubMed DOI PMC
Jensen MB, Jensen CE, Gudex C, et al. Danish population health measured by the EQ-5D-5L. Scand J Public Health. 2021 doi: 10.1177/14034948211058060. PubMed DOI PMC
Burström K, Teni FS, Gerdtham U-G, et al. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. Pharmacoeconomics. 2020;38:839–856. doi: 10.1007/s40273-020-00905-7. PubMed DOI
Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2018;27:7–22. doi: 10.1002/hec.3564. PubMed DOI PMC
Finch AP, Meregaglia M, Ciani O, et al. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration. Soc Sci Med. 2022;292:114519. doi: 10.1016/j.socscimed.2021.114519. PubMed DOI
Ludwig K, Graf von der Schulenburg J-M, Greiner W. German value set for the EQ-5D-5L. Pharmacoeconomics. 2018;36:663–674. doi: 10.1007/s40273-018-0615-8. PubMed DOI PMC
Golicki D, Jakubczyk M, Graczyk K, Niewada M. Valuation of EQ-5D-5L health states in Poland: the first EQ-VT-based study in Central and Eastern Europe. Pharmacoeconomics. 2019;37:1165–1176. doi: 10.1007/s40273-019-00811-7. PubMed DOI PMC
Devlin N, Parkin D, Janssen B. Methods for analysing and reporting EQ-5D data. Springer Nature; 2020. PubMed
Dujardin K, Duhem S, Guerouaou N, et al. Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration. Rev Neurol (Paris) 2021;177:972–979. doi: 10.1016/j.neurol.2020.09.002. PubMed DOI
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x. PubMed DOI
Jensen AK, Lange T (2019) A novel high-power test for continuous outcomes truncated by death. arXiv: 191012267 Stat
Van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.
Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57. doi: 10.1186/1471-2288-9-57. PubMed DOI PMC
Granholm A, Perner A, Krag M, et al. Development and internal validation of the simplified mortality score for the intensive care unit (SMS-ICU) Acta Anaesthesiol Scand. 2017;62:336–346. doi: 10.1111/aas.13048. PubMed DOI
Higgins AM, Peake SL, Bellomo R, et al. Quality of life and 1-year survival in patients with early septic shock: long-term follow-up of the australasian resuscitation in sepsis evaluation trial. Crit Care Med. 2019;47:765–773. doi: 10.1097/CCM.0000000000003762. PubMed DOI
Rc B, Ra B, Fb C, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 doi: 10.1378/chest.101.6.1644. PubMed DOI
Buchholz I, Janssen MF, Kohlmann T, Feng Y-S. A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D. Pharmacoeconomics. 2018;36:645–661. doi: 10.1007/s40273-018-0642-5. PubMed DOI PMC
Calsavara AJC, Nobre V, Barichello T, Teixeira AL. Post-sepsis cognitive impairment and associated risk factors: a systematic review. Aust Crit Care Off J Confed Aust Crit Care Nurses. 2018;31:242–253. doi: 10.1016/j.aucc.2017.06.001. PubMed DOI
Jakobsen JC. When and how should multiple imputation be used for handling missing data in randomised clinical trials—a practical guide with flowcharts. BMC Med Res Methodol. 2017;17:162. doi: 10.1186/s12874-017-0442-1. PubMed DOI PMC
Brown SM, Collingridge DS, Wilson EL, et al. Preliminary validation of the montreal cognitive assessment tool among sepsis survivors: a prospective pilot study. Ann Am Thorac Soc. 2018;15:1108–1110. doi: 10.1513/AnnalsATS.201804-233OC. PubMed DOI
Granholm A, Anthon CT, Kjær M-BN, et al. Patient-important outcomes other than mortality in contemporary ICU trials: a scoping review. Crit Care Med. 2022;50:e759–e771. doi: 10.1097/CCM.0000000000005637. PubMed DOI
Colantuoni E, Scharfstein DO, Wang C, et al. Statistical methods to compare functional outcomes in randomized controlled trials with high mortality. BMJ. 2018;360:j5748. doi: 10.1136/bmj.j5748. PubMed DOI PMC
Meyhoff TS, Sivapalan P, Perner A. Restriction of intravenous fluid in ICU patients with septic Shock. Reply N Engl J Med. 2022;387:857. doi: 10.1056/NEJMc2210366. PubMed DOI
ClinicalTrials.gov
NCT03668236